News
1d
Stockhead on MSNArovella tackles CAR-T’s limitations in cancer treatment with off-the-shelf innovationArovella Therapeutics at forefront of overcoming limitations of CAR-T cell therapy for cancer with its healthy donor-derived ...
The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...
Lori Vallow Daybell is on trial in Maricopa County, Arizona, on one charge of conspiracy to commit the murder of Charles ...
2don MSN
A team of researchers has successfully created more effective immune cells that can fight cancer without damaging healthy tissue.
Lyell Immunopharma (LYEL) announced that the U.S. Food and Drug Administration granted Regenerative Medicine Advanced Therapy, RMAT, ...
Researchers have developed novel lymph-node-inspired hydrogels that significantly enhance the activation, gene expression, ...
Iovance's Amtagvi is the first TIL therapy approved by the U.S. Food and Drug Administration (FDA). Its first approved indication is for advanced melanoma. Amtagvi is off to a great start after its ...
Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient monitoring, proactive adverse effect management, and adapting protocols ...
Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.
Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...
FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...
LEHIGH VALLEY, Pa. - American Cancer Society had some special guests at Saturday's telethon fundraiser. Two guests were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results